Search Results

You are looking at 31 - 40 of 1,305 items for :

  • Refine by Access: All x
Clear All
Full access

Matthew G. Ewend, David E. Morris, Lisa A. Carey, Alim M. Ladha, and Steven Brem

metastases. Histology, multiplicity, surgery, and survival . Cancer 1996 ; 78 : 1781 – 1788 . 2. Patchell RA Tibbs PA Regine WF . Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial . JAMA 1998

Full access

Elizabeth G. Grubbs and Douglas B. Evans

This work was supported by the Faith Fund for Endocrine Surgery Research and Treatment at The University of Texas M. D. Anderson Cancer Center. References 1. Roman S Lin R Sosa JA . Prognosis of medullary thyroid carcinoma

Full access

Daniëlle D. Huijts, Onno R. Guicherit, Jan Willem T. Dekker, Julia T. van Groningen, Leti van Bodegom-Vos, Esther Bastiaannet, Johannes A. Govaert, Michel W. Wouters, and Perla J. Marang-van de Mheen

Background Although surgery has a crucial role in colorectal cancer (CRC) treatment, it is associated with considerable risks of postoperative complications and mortality 1 , 2 and a resultant increase in healthcare costs. 3 Severe complications

Full access

Christopher M. McPherson and Raymond Sawaya

. Neurosurgery 1993 ; 33 : 674 – 678 . 3 Kelly PJ . Stereotactic surgery: what is past is prologue . Neurosurgery 2000 ; 46 : 16 – 27 . 4 Smith KR Frank KJ Bucholz RD . The NeuroStation: a highly accurate, minimally invasive solution

Full access

Matthew P. Banegas, Linda C. Harlan, Bhupinder Mann, and K. Robin Yabroff

treated for localized disease, and nearly 30% will be diagnosed with metastatic disease. 2 While surgery remains the primary treatment for localized RCC, 3 treatment options for metastatic RCC have changed markedly in the past decade. Before 2005

Full access

Robert E. Glasgow, David H. Ilson, James A. Hayman, Hans Gerdes, Mary F. Mulcahy, and Jaffer A. Ajani

patients have distant metastatic disease, extraregional nodal disease, or T4b tumors (involvement of the heart, great vessels, trachea), or are unable to tolerate surgery or multimodality therapy because of insufficient functional status. Even with optimal

Full access

Quan P. Ly and Aaron R. Sasson

. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy . Ann Surg 2000 ; 232 : 743 – 752 . 9. Yun M Lim

Full access

Joyce Y. Wong and Vernon K. Sondak

Acceptable Option for Invasive Melanoma? Mohs micrographic surgery, traditionally considered contraindicated for invasive melanomas, has been studied in melanoma in situ, particularly in cosmetically sensitive areas such as the head and neck. Using this

Full access

Leigh Selesner, Gabrielle Gauvin, Dorotea Mutabdzic, Eileen O’Halloran, Maxwell Kilcoyne, Kwan-Keat Ang, Jeffrey Farma, Elin Sigurdson, and Sanjay Reddy

Introduction: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) has led to improved survival in select patients with peritoneal surface malignancies. Predicting the volume of disease and any unresectable disease is

Full access

Katya Losk, Ines Vaz-Luis, Kristen Camuso, Rafael Batista, Max Lloyd, Mustafa Tukenmez, Mehra Golshan, Nancy U. Lin, and Craig A. Bunnell

delays in adjuvant chemotherapy initiation greater than 49 to 90 days after surgery may be associated with inferior outcomes, particularly among patients with triple-negative breast cancer (TNBC), HER2-positive subtypes, and higher-stage tumors. 7 – 12 A